Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Aptevo Therapeutics Inc
APVO
$
29.53
15%
Wed March 24th, 2021
11:05
Analysis
An Assessment On Aptevo Therapeutics
Seeking Alpha
Wed January 6th, 2021
17:00
Rating
Analysis
Aptevo Therapeutics Inc. (APVO) Upgraded to Buy: Here's Why
Zacks
Wed December 2nd, 2020
18:52
Analysis
Aptevo: Positive Early Stage Data Makes This Highly Interesting
Seeking Alpha
Thu November 19th, 2020
13:30
Press Releases
Analysis
Thinking about buying stock in Aptevo Therapeutics, Electrameccanica Vehicles, AstraZeneca, Corcept Therapeutics, or 22nd Century Group?
PR Newswire
Mon November 16th, 2020
13:16
Press Releases
Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical development
PR Newswire
Wed November 11th, 2020
14:31
Press Releases
Analysis
Thinking about buying stock in Surface Oncology, Northern Oil & Gas, Co-Diagnostics, Howmet Aerospace, or Aptevo Therapeutics?
PR Newswire
Tue November 3rd, 2020
15:40
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Press Releases
Analysis
Thinking about buying stock in Sundial Growers, Aptevo Therapeutics, Aphria Inc, Medifast, or Freeport-McMoRan?
PR Newswire
Tue June 30th, 2020
16:00
Rating
Analysis
All You Need to Know About Aptevo Therapeutics Inc. (APVO) Rating Upgrade to Buy
Zacks
15:30
Analysis
Has Aptevo Therapeutics (APVO) Outpaced Other Medical Stocks This Year?
Zacks
+ 1 more
Thu June 25th, 2020
14:35
Press Releases
Analysis
Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?
PR Newswire
Wed June 10th, 2020
13:37
Press Releases
Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit
PR Newswire
